investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining the role of eIF4F in metastatic castration resistant prostate cancer
Andrew Caleb Hsieh
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Leonard Neckers
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
Prostate
James D. Brooks
Stanford Molecular and Cellular Characterization Laboratory
Prostate
William Figg
Clinical Pharmacogenetics
Prostate
Pathology
Charles L. Sawyers
Understanding Resistance to Next Generation Antiandrogens
Prostate
Fredrick R Schumacher
Imputation-Based Approach to Identify Low Frequency Variants in Prostate Cancer
Prostate
Pathology
Philip Tofilon
Radiation-induced translational control of gene expression
Prostate
Radiation Oncology
Philip A Beachy
Epithelial/stromal signaling in bladder and prostate cell proliferation
Prostate
Pathology
Hans Lilja
Prospective validation of a multi-marker prostate cancer prediction model
Prostate
Ronald G Blasberg
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
Prostate